Literature DB >> 343564

Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.

P Weidmann, R De Chătel, W H Ziegler, J Flammer, F Reubi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 343564     DOI： 10.1016/0002-9149(78)90017-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  15 in total

1.  Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.

Authors:  H J Kornerup; E B Pedersen; N J Christensen; A Pedersen; G Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

2.  Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.

Authors:  H Zschiedrich; W Neurohr; J B Lüth; T Philipp; A Distler
Journal:  Klin Wochenschr       Date:  1983-07-01

3.  Labetalol and urinary catecholamines.

Authors:  R Kolloch; L Miano; V De Quattro
Journal:  Br Med J       Date:  1979-01-27

4.  Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.

Authors:  S Rasmussen; P E Nielsen
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

5.  The use of labetalol in Japan: results of multicentre clinical trials.

Authors:  T Takeda; Y Kaneko; T Omae; K Yoshinaga; Y Masuyama; T Nukada; R Shigiya
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.

Authors:  G Keusch; P Weidmann; W H Ziegler; R de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-01-02

Review 8.  Clinical experience with dual-acting drugs in hypertension.

Authors:  K H Rahn
Journal:  Clin Investig       Date:  1992

9.  Intravenous labetalol in severe hypertension.

Authors:  C Dal Palu; A C Pessina; A Semplicini; M Hlede; F Morandin; P Palatini; G Sperti; G P Rossi
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

10.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.